BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1243 related articles for article (PubMed ID: 25985796)

  • 1. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.
    Mishra RK; Yang W; Roy J; Anderson AH; Bansal N; Chen J; DeFilippi C; Delafontaine P; Feldman HI; Kallem R; Kusek JW; Lora CM; Rosas SE; Go AS; Shlipak MG;
    Circ Heart Fail; 2015 Jul; 8(4):702-8. PubMed ID: 25985796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
    Tummalapalli SL; Zelnick LR; Andersen AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
    J Am Heart Assoc; 2020 Jul; 9(13):e014385. PubMed ID: 32578483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
    Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
    Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
    Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Health Status and Incidence of Heart Failure in the Framingham Offspring Study.
    Nayor M; Enserro DM; Vasan RS; Xanthakis V
    Circ Heart Fail; 2016 Jan; 9(1):e002416. PubMed ID: 26699391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
    Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.
    Smith DH; Thorp ML; Gurwitz JH; McManus DD; Goldberg RJ; Allen LA; Hsu G; Sung SH; Magid DJ; Go AS
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):333-42. PubMed ID: 23685625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication - results from the CAVASIC Study.
    Rantner B; Pohlhammer J; Stadler M; Peric S; Hammerer-Lercher A; Klein-Weigel P; Fraedrich G; Kronenberg F; Kollerits B
    Atherosclerosis; 2015 Apr; 239(2):428-35. PubMed ID: 25682043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.
    Bansal N; Zelnick L; Robinson-Cohen C; Hoofnagle AN; Ix JH; Lima JA; Shoben AB; Peralta CA; Siscovick DS; Kestenbaum B; de Boer IH
    J Am Heart Assoc; 2014 Dec; 3(6):e001278. PubMed ID: 25468653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study.
    Garimella PS; Katz R; Patel KV; Kritchevsky SB; Parikh CR; Ix JH; Fried LF; Newman AB; Shlipak MG; Harris TB; Sarnak MJ;
    Circ Heart Fail; 2016 Jan; 9(1):e002124. PubMed ID: 26721912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; PiƱa IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.
    de Simone G; Devereux RB; Roman MJ; Chinali M; Barac A; Panza JA; Lee ET; Galloway JM; Howard BV
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):285-91. PubMed ID: 21940153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
    Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
    Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort.
    Dubin RF; Deo R; Bansal N; Anderson AH; Yang P; Go AS; Keane M; Townsend R; Porter A; Budoff M; Malik S; He J; Rahman M; Wright J; Cappola T; Kallem R; Roy J; Sha D; Shlipak MG;
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):60-68. PubMed ID: 28062676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure.
    Hsu CP; Lin SJ; Chung MY; Lu TM
    Atherosclerosis; 2012 Dec; 225(2):504-10. PubMed ID: 23092827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.
    Ledwidge M; Gallagher J; Conlon C; Tallon E; O'Connell E; Dawkins I; Watson C; O'Hanlon R; Bermingham M; Patle A; Badabhagni MR; Murtagh G; Voon V; Tilson L; Barry M; McDonald L; Maurer B; McDonald K
    JAMA; 2013 Jul; 310(1):66-74. PubMed ID: 23821090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer Paced QRS Duration is Associated With Increased Prevalence of Right Ventricular Pacing-Induced Cardiomyopathy.
    Khurshid S; Liang JJ; Owens A; Lin D; Schaller R; Epstein AE; Marchlinski FE; Frankel DS
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1174-1179. PubMed ID: 27457998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.